We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Neonatal Characteristics in Rapidly Progressive Perinatally Acquired HIV-1 Disease

Marie-Jeanne Mayaux; Marianne Burgard, MD; Jean-Paul Teglas, MS; Jacqueline Cottalorda, MD; Anne Krivine, MD; François Simon, MD; Jacqueline Puel, MD; Catherine Tamalet, MD; Dominique Dormont, MD; Bernard Masquelier, MD; Anne Doussin, MD; Christine Rouzioux, PhD; Stéphane Blanche, MD; B. Pautard; D. Brault; J. Mamou; A. Broyart; M. Dandine; X. Hernandorena; P. Balde; E. Lachassine; D. Douard; H. Fleury; B. Masquelier; I. Gilles; A. Gantzer; A-M. Colin-Gorki; J. Brouard; F. Freymuth; L. Keros; P. Labrune; M. Vial; F. Mazy; C. Floch; P. Bourdon; M. Duval-Arnould; C. Huraux-Rendu; S. Lemerle; M. Boddaert; M-F. Denavit; K. Lahsinat; C. Pascal; A. Leblanc; A. May; C. Dallot; D. Dormont; B. Bader-Meunier; E. Dussaix; M. Tardieu; H. Seaume; P. Wipff; P. Deboisse; G. Michel; C. Tamalet; D. Vallée; C. Crumière; A. Saillant; B. Le Lorier; C. Botto; D. Seguy; P. Talon; C. Huret; J. Nicolas; J. Lalande; F. Mechineau-Lacroix; D. Berterottière; J. Cottalorda; A. Deville; F. Monpoux; A. de Crepy; F. Simon; S. Parat; G. Firtion; M. Ronzier; C. Brunner; N. Ciraru-Vigneron; B. Heller-Roussin; S. Blanche; M. Burgard; D. Girault; C. Rouzioux; J. Terris; F. Veber; J-M. Huraux; G. Noseda; M. Levine; E. Vilmer; A. Vallet; L. Marpeau; F. Parnet Mathieu; C. Aufrant; C. Francoual; A. Krivine; F. Hervé; C. Courpotin; C. Dollfus; C. Carlus Moncomble; M-C. Rousset; G. Mouchnino; V. Brossard; C. Buffet-Janvresse; M. Robin; F. Labbe-Filou; M. C. Allemon; J.-M. Retbi; P. Narcy; A.-M. Raison Boulley; J. Puel; J. Tricoire; F. Barin; J.-C. Borderon; R. Busuttil; A. Vinas; F. Guillot; A. Lacroix-Coutry.
JAMA. 1996;275(8):606-610. doi:10.1001/jama.1996.03530320030030.
Text Size: A A A
Published online


Objective.  —To identify clinical and laboratory parameters at birth that are associated with the rapidly progressive form of human immunodeficiency virus type 1 (HIV-1) disease in children born to infected mothers.

Design.  —Multicenter, prospective study of infants born to HIV-seropositive mothers.

Setting.  —A total of 62 obstetric and pediatric centers in France.

Participants.  —Of 1386 children born to HIV-1—seropositive mothers at least 18 months before the cutoff date, 267 were infected. Infection was defined as serological positivity at 18 months or death from HIV disease before this age.

Main Outcome Measure.  —Category C events (including opportunistic infections, recurrent severe bacterial infections, cancers, specific encephalopathy, and wasting syndrome) in the new pediatric Centers for Disease Control and Prevention classification during the first year of life, according to clinical, immunological, and virological findings at birth.

Results.  —The risk of category C manifestations at 12 months was significantly higher when an infected newborn had liver and/or spleen enlargement and/or adenopathies (38.1% vs 15.1%; relative risk [RR], 2.5; 95% confidence interval [CI], 1.4 to 6.0; P<.02) or a low proportion (<30%) of CD4+ cells at birth (45.5% vs 15.0%; RR, 3.0; 95% CI, 1.4 to 6.4; P<.005). Similarly, HIV-1 culture and/or polymerase chain reaction positivity during the first week of life was associated with a higher risk of the early, severe form of HIV infection (26.4% vs 9.3%; RR, 2.8; 95% CI, 1.3 to 6.1; P<.006). In case of positive antigenemia at birth, the risk was 50.0% vs 14.4% (RR, 3.5; 95% CI, 1.9 to 6.2; P<.001 ). These parameters, determined at birth, were strongly interrelated and could reflect active disease onset in utero in some cases of early, severe HIV-1 disease in childhood.

Conclusions.  —These prognostic markers, particularly virological parameters, are of value in monitoring children infected by HIV and might serve as a basis for early therapeutic intervention.(JAMA. 1996;275:606-610)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.